Automating drug discovery

Schneider, Gisbert·2018·Nature Reviews Drug Discovery

Cites (252)

Items 201–251 of 251

  1. The Pictet-Spengler Reaction Still on Stage
    Cinzia Ingallina, Ilaria D’Acquarica, Giuliano Delle Monache, Francesca Ghirga, Deborah Quaglio, Patrizio Ghirga, Simone Berardozzi, Violeta R. Marković, Bruno Botta · 2015 · Current Pharmaceutical Design
  2. Modeling the Blood-Brain Barrier in a 3D triple co-culture microfluidic system
    Giulia Adriani, Dongliang Ma, Andrea Pavesi, Eyleen L. K. Goh, Roger Dale Kamm · 2015 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  3. Representing high throughput expression profiles via perturbation barcodes reveals compound targets
    Filzen, Tracey M., Kutchukian, Peter S., Hermes, Jeffrey D., Li, Jing, Tudor, Matthew · 2017 · PLOS Computational Biology
  4. Automated Flow-Through Synthesis of Heterocyclic Thioethers
    Daniel Jönsson, Brian H. Warrington, Mark Ladlow · 2004 · Journal of Combinatorial Chemistry
  5. Generative Models for Chemical Structures
    David J. White, Richard C. Wilson · 2010 · Journal of Chemical Information and Modeling
  6. Distant Polypharmacology among MLP Chemical Probes
    Albert A. Antolín, Jordi Mestres · 2014 · ACS Chemical Biology
  7. Function-Oriented Synthesis: How to Design Simplified Analogues of Antibacterial Nucleoside Natural Products?
    Satoshi Ichikawa · 2016 · The Chemical Record
  8. Do Medicinal Chemists Learn from Activity Cliffs? A Systematic Evaluation of Cliff Progression in Evolving Compound Data Sets
    Dilyana Dimova, Kathrin Heikamp, Dagmar Stumpfe, Jürgen Bajorath · 2013 · Journal of Medicinal Chemistry
  9. No Denying It: Medicinal Chemistry Training Is in Big Trouble
    Michael F. Rafferty · 2016 · Journal of Medicinal Chemistry
  10. Big-Data-Driven Stem Cell Science and Tissue Engineering: Vision and Unique Opportunities
    Antonio del Sol, H.-J. Thiesen, Jaime Imitola, Rafael E. Carazo Salas · 2017 · Cell stem cell
  11. Does ‘Big Data’ Exist in Medicinal Chemistry, and If So, How can It Be Harnessed?
    Igor V. Tetko, Ola Engkvist, Hongming Chen · 2016 · Future Medicinal Chemistry
  12. ChemInform Abstract: Diversity‐Oriented Synthesis: Producing Chemical Tools for Dissecting Biology
    Cornelius J. O’Connor, Henning S. G. Beckmann, David R. Spring · 2012 · ChemInform
  13. Dynamic Combinatorial Chemistry: Evolutionary Formation and Screening of Molecular Libraries
    A. V. Eliseev, Jean‐Maríe Lehn · 1999 · Current topics in microbiology and immunology
  14. Synthesis of new hydrophilic rhodamine based enzymatic substrates compatible with droplet-based microfluidic assays
    Johan Fenneteau, Dany Chauvin, Andrew D. Griffiths, Clément Nizak, Janine Cossy · 2017 · Chemical Communications
  15. Electrochemical imaging for microfluidics: a full-system approach
    Adnane Kara, Arnaud Reitz, Jessy Mathault, Syllia Mehou-Loko, Mehran Abbaszadeh Amirdehi, Amine Miled, Jesse Greener · 2016 · Lab on a Chip
  16. An eco-compatible strategy for the diversity-oriented synthesis of macrocycles exploiting carbohydrate-derived building blocks
    Sushil K. Maurya, Rohit Rana · 2017 · Beilstein Journal of Organic Chemistry
  17. Intelligent software for laboratory automation
    Ken E. Whelan, Ross D. King · 2004 · Trends in biotechnology
  18. Steering Target Selectivity and Potency by Fragment‐Based De Novo Drug Design
    Tiago Rodrigues, Takayuki Kudoh, Filip Roudnicky, Yi Fan Lim, Yen‐Chu Lin, Christian P. Koch, Masaharu Seno, Michael J. Detmar, Gisbert Schneider · 2013 · Angewandte Chemie International Edition
  19. An integrated chemical biology approach reveals the mechanism of action of HIV replication inhibitors
    Nicholas Pagano, Peter Teriete, Margrith E. Mattmann, Li Yang, Beth A. Snyder, Zhaohui Cai, Marintha L. Heil, Nicholas D. P. Cosford · 2017 · Bioorganic & Medicinal Chemistry
  20. Combinatorial Chemistry by Ant Colony Optimization
    Jan A. Hiss, Michael Reutlinger, Christian P. Koch, Anna Maria Perna, Petra Schneider, Tiago Rodrigues, Sarah Haller, Gerd Folkers, Lutz Weber, Renato B. Baleeiro et al. · 2014 · Future Medicinal Chemistry
  21. Semantic inference using chemogenomics data for drug discovery
    Qian Zhu, Yuyin Sun, Sashikiran Challa, Ying Ding, Michael S. Lajiness, David J. Wild · 2011 · BMC Bioinformatics
  22. Corrigendum: Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem Activity Cliffs, and QSAR
    David Alan Winkler, Tu C. Le · 2017 · Molecular Informatics
  23. Identification of Hits and Lead Structure Candidates with Limited Resources by Adaptive Optimization
    Andreas Schüller, Gisbert Schneider · 2008 · Journal of Chemical Information and Modeling
  24. Physicochemical Effects in the Representation of Molecular Structures for Drug Designing
    Johann Gasteiger · 2003 · Mini-Reviews in Medicinal Chemistry
  25. Enabling Chemistry Technologies and Parallel Synthesis—Accelerators of Drug Discovery Programmes
    Anil Vasudevan, Andrew R. Bogdan, Hannes F. Koolman, Y. Wang, Stevan W. Djurić · 2017 · Progress in medicinal chemistry
  26. De novo Molecular Design
    Gisbert Schneider · 2013
  27. Starting material oriented retrosynthetic analysis in the LHASA program. 3. Heuristic estimation of synthetic proximity
    A. Peter Johnson, Chris Marshall · 1992 · Journal of Chemical Information and Computer Sciences
  28. Embarking on a Chemical Space Odyssey
    Shiao Y. Chow, Adam S. Nelson · 2017 · Journal of Medicinal Chemistry
  29. ADAAPT: Amgen's data access, analysis, and prediction tools
    Sung Jin Cho, Yaxiong Sun, William E. Harte · 2006 · Journal of Computer-Aided Molecular Design
  30. Representation of probabilistic scientific knowledge
    Larisa Soldatova, Andrey Rzhetsky, Kurt De Grave, Ross D. King · 2013 · Journal of Biomedical Semantics
  31. Development of a Specific Substrate—Inhibitor Panel (Liver-on-a-Chip) for Evaluation of Cytochrome P450 Activity
    A. A. Zakhariants, Olga Burmistrova, M. Yu. Shkurnikov, Andrey A. Poloznikov, D. A. Sakharov · 2016 · Bulletin of Experimental Biology and Medicine
  32. Towards a Multifunctional Electrochemical Sensing and Niosome Generation Lab-on-Chip Platform Based on a Plug-and-Play Concept
    Adnane Kara, C. Rouillard, Jessy Mathault, M. Boisvert, F. Tessier, Hamza Landari, I. Melki, M. Laprise-Pelletier, É. Boisselier, M. Fortin et al. · 2016 · Italian National Conference on Sensors
  33. Reaction screening and optimization of continuous-flow atropine synthesis by preparative electrospray mass spectrometry
    Caitlin E. Falcone, Zinia Jaman, Michael Wleklinski, Andy Koswara, David H. Thompson, R. Graham Cooks · 2017 · The Analyst
  34. Structure Modification toward Applicability Domain of a QSAR/QSPR Model Considering Activity/Property
    Shoki Ochi, Tomoyuki Miyao, Kimito Funatsu · 2017 · Molecular Informatics
  35. Microstructured reactors as tools for the intensification of pharmaceutical reactions and processes.
    Paul Chin, William S. Barney, Bradford A. Pindzola · 2009 · PubMed
  36. De novo Drug Design – Ye olde Scoring Problem Revisited
    Gisbert Schneider, Kimito Funatsu, Yasushi Okuno, David Alan Winkler · 2017 · Molecular Informatics
  37. March of the synthesis machines
    Katharine Sanderson · 2015 · Nature Reviews Drug Discovery
  38. Miniaturized GPCR signaling studies in 1536-well format.
    S Shultz, Tracy J Worzella, Aoife Gallagher, Jeng-Jong J. Shieh, Said A. Goueli, Kai-Ching Hsiao, Jolanta Vidugirienė · 2008 · PubMed Central
  39. Embedding Sustainable Practices into Pharmaceutical R&D: What are the Challenges?
    Helen F. Sneddon · 2014 · Future Medicinal Chemistry
  40. Extending ‘Predict First’ to the Design-Make-Test Cycle in Small-Molecule Drug Discovery
    Scott T. Harrison, Brian R. Lahue, Zhengwei Peng, Anthony E. Donofrio, Charlie Chang, Meir Glick · 2017 · Future Medicinal Chemistry
  41. Flashback Forward: Reaction-Driven De Novo Design of Bioactive Compounds
    Gisbert Schneider, Tiago Rodrigues · 2013 · Synlett
  42. Microreactors as New Tools for Drug Discovery and Development
    Stephanie Y. F. Wong, Joseph Matteo, B. H. Warrington, Joseph White · 2007 · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings
  43. Automation of decision making in drug design
    David E. Leahy, Vladimir Joseph Sykora · 2013 · Drug Discovery Today Technologies
  44. Where will we get the next generation of medicinal chemists?
    Dave Allen · 2016 · Drug Discovery Today
  45. ACS National Meeting - Exposition
    2016 · C&EN Global Enterprise
  46. Design Issues of Big Data Parallelisms
    Koushik Mondal · 2016 · Advances in intelligent systems and computing
  47. Current status and future prospects for enabling chemistry technology in the drug discovery process
    Stevan W. Djurić, Charles W. Hutchins, Nari N. Talaty · 2016 · F1000Research
  48. Overview of Combinatorial Chemistry
    Stephen L. Crooks, Leslie J. Charles · 2000 · Current Protocols in Pharmacology
  49. Parallel Chemistry in the 21st Century
    Alan Long · 2012 · Current Protocols in Pharmacology
  50. P2P proteomics -- data sharing for enhanced protein identification
    Marco Schorlemmer, Joaquín Abián, Carles Sierra A, David de la Cruz, Lorenzo Bernacchioni, Enric Jaén, Adrián Perreau de Pinninck, Manuel Atencia · 2012 · Automated Experimentation
  51. Robot wars
    2009 · Nature Chemistry